Silica gel 60 coated aluminum sheets containing fluorescence indicator (Merck KGaA, Darmstadt, Germany) were used for thin layer chromatography (TLC). UV light (254 nm) and aqueous KMnO4 solution or a molybdate solution (0.02 M ammonium cerium sulfate dihydrate and 0.02 M ammonium molybdate tetrahydrate in aqueous 10% H2SO4) were used for development. Medium pressure liquid chromatography (MPLC) was performed on a Teledyne Isco Combiflash Rf200 system using pre-packed silica gel 60 columns from Teledyne Isco, SiliCycle or Macherey-Nagel. Nuclear magnetic resonance (NMR) spectroscopy was performed on a Bruker Avance III 500 UltraShield spectrometer at 500 MHz ( 1 H) or 126 MHz ( 13 C) or a Bruker Fourier300 spectrometer at 300 MHz ( 1 H) or 75 MHz ( 13 C). Chemical shifts are given in ppm and were calibrated on residual solvent peaks as internal standard. Multiplicities were specified as s (singlet), d (doublet), t (triplet) or m (multiplet). The signals were assigned with the help of 1 H, 1 H -COSY, DEPT-135-edited 1 H, 13 C-HSQC and 1 H, 13 C-HMBC experiments. Mass spectra were obtained on Thermo Dionex 3000 HPLC frontend coupled to a Bruker amaZon SL and the data were analyzed using DataAnalysis from Bruker (Bremen, Germany) or on a Thermo SpectraSystem HPLC frontend coupled to a Finnigan Surveyor MSQ Plus.
GOP E: Alkaline ester hydrolysis:
The ester (1 equiv) was dissolved in dioxane (5 mL/mmol), 1.1 equiv of an aqueous 1 M NaOH solution was added at 0 °C under stirring and after 1 h the solvent was removed under reduced pressure. The residue was redissolved with H2O (40 mL/mmol) and acidified with 2 M HCl to pH = 2. The aqueous phase was extracted with EtOAc (3 × 50 mL/mmol), the combined organic layers were dried over Na2SO4, filtered and the solvent was removed under reduced pressure to give the free acid.
GOP F: Synthesis of tripeptide SNAc-ester:
To a solution of the carboxylic acid (1 equiv) in CH2Cl2 (15 mL/mmol) was added DIPEA (2 equiv) and the solution was cooled to 0 °C. After addition of TFFH (1.1 equiv) the solution was stirred for 15 min at 0 °C. Nacetylcysteamine (1.1 equiv) was added portion-wise and the reaction mixture was stirred at 0 °C until the reaction was completed (TLC). The reaction mixture was diluted with EtOAc (150 mL/mmol), washed with satd. NaHCO3 (3 × 75 mL/mmol) and with brine (1 × 75 mL/mmol). The organic layer was dried over Na2SO4, filtered and the solvent was removed under reduced pressure. Purification by flash column chromatography (linear gradient of CH2Cl2/EtOH 0-7%) gave the SNAc esters. N-Boc-L-Ala-Gly-OMe (20a). The compound was synthesized according to GOP B using Boc-L-Ala-OH (189 mg, 1.0 mmol), Gly-OMe · HCl (138 mg, 1.1 mmol), IBCF (142 µL, 1.1 mmol), NMM (132 µL, 1.2 mmol). Purification gave Boc-L-Ala-Gly-OMe (20a) (216 mg, 0.83 mmol, 83%) as colorless oil. 1 H NMR (500 MHz, CHCl3-d1) δ 6.81 (br-s, 1H, NH), 5.10 (br-d, J = 7. 6 Hz, 1H, NH), 4.23 (br-s, 1H, CH), 4.03 (t, J = 4.8 Hz, 2H, Gly-CH2), 3.74 (s, 3H, OCH3), 1.43 (s, 9H, Boc-CH3), 1.37 (d, J = 7.1 Hz, 3H, Ala-CH3), 13 05 . Proton NMR data correspond to the literature. [2] N-Boc-D-Ala-Gly-OMe (20b). The compound was synthesized according to GOP B using Boc-D-Ala-OH (189 mg, 1.0 mmol), Gly-OMe · HCl (138 mg, 1.1 mmol), IBCF (142 µL, 1.1 mmol), NMM (132 µL, 1.2 mmol). Purification gave Boc-D-Ala-Gly-OMe (20b) (220 mg, 0.85 mmol, 85%) as colorless oil. 1 
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(500 MHz, CHCl3-d1) δ 1H, NH), 1H, NH), 4.22 (s, 1H, CH), 2H, , 3 .75 (s, 3H, OCH3), 1.44 (s, 9H, Boc-CH3), 1.37 (d, J = 7. 1 Hz, 3H, , 13 . The compound was synthesized according to GOP A using Boc-L-Ala-OH (206 mg, 1.09 mmol), 0.99 mmol) , PyBOP (567 mg, 1.09 mmol), DIPEA (407 µL, 2.37 mmol). Purification gave the title compound 20c (256 mg, 0.89 mmol, 89%) as colorless oil. 1 D-Ala-Gly-OMe * HCl (21b). The compound was synthesized according to GOP C using Boc-D-Ala-Gly-OMe (203 mg, 0.78 mmol) and 4 M HCl/dioxane (2.5 mL, 10 .0 mmol). The solvent was removed under S5 reduced pressure to give 21b (153 mg, 0.78 mmol, quant.) as colorless oil. 1 L-Ala-Sar-OEt * HCl (21c). The compound was synthesized according to GOP C using Boc-L-Ala-Sar-OEt (236 mg, 0.82 mmol) and 4 M HCl/dioxane (3.0 mL, 12.0 mmol). The solvent was removed under reduced pressure to give 21c (184 mg, 0.82 mmol, quant.) as colorless oil. 1 
N-Boc-L-Ala-
N-Boc-D-Ala-L-Ala-Gly-OH (23a).
The compound was synthesized according to GOP E using Boc-D-Ala-L-Ala-Gly-OMe (111 mg, 0.34 mmol) and 1 M NaOH (400 µL, 0.40 mmol). After workup 23a (92 mg, 0.29 mmol, 85%) was obtained as white amorphous solid. 1 Gly-OMe (33b) . The compound was synthesized according to GOP D using Boc-D-Ala-L-Ser(OBn)-Gly-OMe (330 mg, 0.75 mmol) and Pd/C (33 mg, 10 wt %). After filtration the solvent was evaporated to give 33b (254 mg, 0.73 mmol, 97%). 1 (35b) . Boc-D-Ala-Dha-Gly-OMe (34b) (33 mg, 0.10 mmol) was dissolved in 1.75 mL of THF/MeOH/H2O (4/1/2) and cooled to 0 °C. Aqueous 0.5 N LiOH (219 µL, 0.11 mmol) was added and the reaction mixture was stirred for 30 min. Then, the reaction was diluted with CH2Cl2 (10 mL) and the organic layer was washed with KHSO4 (1 × 8 mL) and subsequently the aqueous layer was reextracted with CH2Cl2 (2 × 10 mL). The combined organic layers were dried over Na2SO4, filtered and the solvent was removed under reduced pressure. The crude product was directly converted according to GOP F using Boc-D-Ala-Dha-Gly-OH (31 mg, 0.10 mmol), TFFH (29 mg,0.11 mmol), N-acetylcysteamine (13 mg, 0.11 mmol) and DIPEA (34 µL, 0.20 mmol). Purification by flash column chromatography gave 35b (12 mg, 0.03 mmol, 30%) as yellowish solid. 1 
N-Boc-D-Ala-L-Ser(OH)-
N-Boc-D-Ala-Dha-Gly-SNAc
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In order to evaluate stability of the synthetic tripeptide mimic, its degradation kinetics was evaluated under the standard cultivation conditions. Two mL Eppendorf tube was filled with two mL of the cultivation medium supplemented with 25 µL of the tripeptide DMSO stock solution (12 mg/mL) and incubated at 30 °C, 800 rpm in the heat block. A 100 µL sample was taken every 2 h, centrifuged at 15000 rpm, 4 °C for 5 min and supernatant was subjected to HPLC-MS analysis: column EC150/2 Nucleoshell HILIC 2.7 µM (Macherey-Nagel, Germany), buffer A: 100 mM ammonium formate buffer B: MeCN / 0.1% HCO2H, gradient of 5%A to 12% A over 12 min (flow 800 µL/min), (Fig. S2) .
Co-expression of arg2 in M. xanthus DK1622 ∆mchA-tet::pArg345-V1
Plasmid pGH-arg2-V1 (Pogorevc et al., unpublished data) was hydrolyzed by HindIII/XbaI to excise arg2 fragment which was subsequently ligated into pDKzeo1 [6] plasmid hydrolyzed with the same enzymes, to produce pDKzeo1-arg2-V1. To introduce PnptII promoter upstream of the arg2 gene, a 208 bp fragment was amplified from pArg2345-V1 using oligonucleotides Arg47 (CACCAAGCTTTGAA-TGCGCAAACCAACC) and Arg48 (CTAGGTCAGGGCATATGATC). The resulting PnptII promoter fragment and the expression plasmid pDKzeo1-arg2-V1 were hydrolyzed by HindIII/NdeI restriction enzymes and ligated to produce pDKzeo1-nptII-arg2-V1. The heterologous host M. xanthus DK1622 ∆mchAtet::pArg345-V1 was transformed with the generated expression construct by electroporation. Correct mutants were selected on CTT agar supplemented with 50 µg/mL zeocin plus 50 µg/mL kanamycin and genotypic verification of the mutants was performed according to the previously described procedure (Pogorevc et al., unpublished data). The obtained mutant was cultivated in comparison to the control strain M. xanthus DK1622
ΔmchA-tet::pArg2345-V1 and argyrin production was evaluated by HPLC-MS analysis of the culture extracts.
The mutant strain M. xanthus DK1622 ∆mchA-tet::pArg345-V1/pDKzeo1-nptII-arg2 showed the same argyrin production profile as the control strain.
In vitro reconstitution of argyrin using cell lysate
The mutant expressing Arg2 subunit (DK1622 ∆mchA-tet::pDKzeo1-nptII-arg2) was generated by transformation of previously generated construct pDKzeo1-nptII-arg2 into the DK1622 ∆mchA-tet heterologous host. Correct mutants were selected on CTT agar supplemented with 50 µg/mL zeocin and genotypic verification of the mutants was performed according to the previously described procedure (Pogorevc et al., unpublished data) . The mutant strains DK1622 ∆mchA-tet::pDKzeo1-nptII-arg2 and M.
xanthus DK1622 ∆mchA-tet::pArg345-V1 were cultivated in CTT medium supplemented with 50 µg/mL zeocin and 50 µg/mL kanamycin, respectively. After 24-48 h of cultivation or when the culture OD600 reached around 1.0, the cultures were harvested by centrifugation at 10000g, 4 °C for 15 min. Cell pellets were washed with brine twice, before cells were resuspended in lysis buffer (2 mM DTT, 50 mM Tris-HCl (pH 7.5), 150
mM NaCl, 10 mM MgCl2) and disrupted by sonication. Two mL of lysis buffer was used per 1 g of cell pellet.
The homogenate was clarified by centrifugation at 80000g, 4 °C, 10 min. Total protein concentration in cell lysates was measured by nano drop. In vitro assay was performed in total volume of 50 µL containing reaction S19 buffer (50 mM Tris-HCl (pH 7.5 or 8.0), 150 mM NaCl, 10 mM MgCl2), 3 mM ATP, 1 mM substrate amino acid mixture (alanine, serine, glycine, cysteine, tryptophan) and a mixture of both cell lysates containing Arg2
and Arg3-Arg5 proteins, respectively. Varying volumes of cell lysate mixture were used, ranging from 0.05 mg to 0.8 mg of total protein content. In vitro reconstitution was performed by incubation for 2 h or 4 h at room temperature (22 °C) or 30 °C. After incubation the samples were extracted by addition of 50 µL MeOH, centrifuged at 4 °C for 15 min and the supernatant was analysed by HPLC-MS.
HPLC-MS method for analysis of argyrin mutasynthesis and in vitro reconstitution samples
All measurements were performed on a Dionex Ultimate 3000 RSLC system using a Waters BEH C18, 50 × 2.1 mm, 1.7 µm dp column. Separation of 1 µL sample was achieved by a linear gradient with (A) H2O + 0.1%
FA to (B) ACN + 0.1% FA at a flow rate of 600 µL/min and 45 °C. The gradient was initiated by a 1 min isocratic step at 5% B, followed by an increase to 95% B in 6 min to end up with a 1.5 min step at 95% B before reequilibration under the initial conditions. UV spectra were recorded by a DAD in the range from 200 to 600 nm. The LC flow was split to 75 µL/min before entering the maXis 4G hr-ToF mass spectrometer (Bruker Daltonics, Bremen, Germany) using the standard ESI source. Mass spectra were acquired in centroid mode ranging from 150 -2000 m/z at a 2 Hz scan speed. Figure S1 . Mutasynthesis approach for production of argyrins. An expression strain harboring a truncated arg BGC lacking arg1 and arg2 (encoding the first subunit Arg2 of the argyrin NRPS megasynthetase) is fed with mutasynthons to restore argyrin production. Mutasynthons represent mimics of natural or unnatural tripeptide intermediates. 
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